Sana Biotechnology trades at a steep discount despite promising T1D assets UP421 and SC451. Check out why SANA stock is a buy ...

Launched on June 23, 2005, the Invesco Biotechnology & Genome ETF (PBE) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the ...

The latest update cuts the fair value price target for PDS Biotechnology from US$5.75 to US$4.75, signaling a more conservative valuation anchor for the stock. Analysts link this change to a mix of ...

Hangzhou Diagens Biotechnology has just come through a volatile spell, and the sharp moves now put a simple question on the table for you as a shareholder or potential buyer: Is the current Hong Kong ...

Vir Biotechnology is now a two-engine company, with major pharma partnerships and a fully enrolled hepatitis delta phase 3 program. See why VIR stock is a buy.

Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...

TRex Bio and Retension Pharmaceuticals are set to continue the industry’s public debut rebound.

Vir Biotechnology has appointed Aziz Sawaf as Executive Vice President and Chief Financial Officer, effective October 5, 2026 ...

Shulkin was the ninth secretary of the U.S. Department of Veterans Affairs in the Trump administration and undersecretary for health in the Obama administration. Biotechnology is rapidly becoming a ...

Researchers identify GmRVE4d as a gene that delays soybean flowering and maturity by repressing GmPRR5a. This finding highlights GmRVE4d as a potential breeding target for improving soybean adaptation ...

Leading biotechnology, public health, and science communication specialists had a two-day writeshop to equip local government leaders and public servants with science-based tools for agricultural ...